Cipla gets USFDA nod for hypertension, cardiac drug

The company has received final nod from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Metoprolol ER tablets in the strengths of 50mg, 100mg and 200mg, Cipla said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2EOKfJZ